Wednesday, July 8, 2026

pharma · Cholestatic liver disease · Cystic Fibrosis · PRQR

ProQR Therapeutics N.V

ProQR Therapeutics N.V clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Leiden, NL HQ
2012 Founded
204 Employees
Public company Type
PRQR · NYSE Ticker
Company details
Status
Public
HQ
Leiden, NL
Founded
2012
Employees
204
Programs
6
Drugs
2
Patents
19
Intelligence · Clinical Programs

ProQR Therapeutics N.V projects

1 ClinicalTrials.gov programs sponsored by ProQR Therapeutics N.V.

ProQR Therapeutics N.V has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. sepofarsen

    ProQR Therapeutics N.V.

    Leber Congenital Amaurosis 10

    phase 3 small molecule active

    2 trials

Frequently asked questions

How many clinical projects does ProQR Therapeutics N.V have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.